Literature DB >> 7957832

Deposition of inhaled particles in the mouth and throat of asthmatic subjects.

K Svartengren1, P A Lindestad, M Svartengren, G Bylin, K Philipson, P Camner.   

Abstract

We previously studied the deposition of inhaled particles in the mouth and throat of asthmatic patients, and found large, reproducible differences among subjects. In the present study, we examined whether anatomical and/or functional differences in the pharynx and larynx could underlie this interindividual variation. Deposition in the mouth and throat, and in the lung was estimated in 16 asthmatic subjects after inhalation of 3.6 microns (aerodynamic diameter) monodisperse Teflon particles labelled with 111In. The particles were inhaled at a flow rate of 0.5 l.s-1 with maximally deep breaths. Radioactivity was measured by external scanning over head and neck, lungs and stomach, immediately after the inhalation. Radioactivity in the lungs was also measured 24 h later. A measure of the total amount of particles deposited in the mouth and throat was obtained from the added activities in mouthwash, head and neck, and stomach, immediately after the inhalation of the test particles. Pharynx and larynx function was examined by fibreoptic laryngoscopy performed during a corresponding inhalation procedure. Deposition in the mouth and throat varied widely among the subjects, ranging 9-76% (median 12%). We found two subpopulations, 13 subjects in the range 9-34%, and 3 subjects with > 70% deposition. Deviations in pharyngeal configuration during inhalation were significantly related to high mouth and throat deposition, whereas functional differences in the larynx were not. Our study shows that mouth and throat deposition may be extremely high in some asthmatics, and that pharyngeal configuration affects deposition of particles in the mouth and throat.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7957832     DOI: 10.1183/09031936.94.07081467

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  9 in total

1.  Surfactant Driven Post-Deposition Spreading of Aerosols on Complex Aqueous Subphases. 1: High Deposition Flux Representative of Aerosol Delivery to Large Airways.

Authors:  Amsul Khanal; Ramankur Sharma; Timothy E Corcoran; Stephen Garoff; Todd M Przybycien; Robert D Tilton
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2015-02-27       Impact factor: 2.849

2.  Suitability of the upper airway models obtained from MRI studies in simulating drug lung deposition from inhalers.

Authors:  T Ehtezazi; K W Southern; D Allanson; I Jenkinson; C O'Callaghan
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

3.  Introduction: Aerosol delivery of orally inhaled agents.

Authors:  Timothy E Corcoran; Sunalene G Devadason; Philip J Kuehl
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2012-12       Impact factor: 2.849

4.  Surfactant Driven Post-Deposition Spreading of Aerosols on Complex Aqueous Subphases. 2: Low Deposition Flux Representative of Aerosol Delivery to Small Airways.

Authors:  Ramankur Sharma; Amsul Khanal; Timothy E Corcoran; Stephen Garoff; Todd M Przybycien; Robert D Tilton
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2015-03-10       Impact factor: 2.849

5.  Surfactant-induced Marangoni transport of lipids and therapeutics within the lung.

Authors:  Amy Z Stetten; Steven V Iasella; Timothy E Corcoran; Stephen Garoff; Todd M Przybycien; Robert D Tilton
Journal:  Curr Opin Colloid Interface Sci       Date:  2018-01-13       Impact factor: 6.448

6.  Quasi-immiscible spreading of aqueous surfactant solutions on entangled aqueous polymer solution subphases.

Authors:  Ramankur Sharma; Timothy E Corcoran; Stephen Garoff; Todd M Przybycien; Ellen R Swanson; Robert D Tilton
Journal:  ACS Appl Mater Interfaces       Date:  2013-06-10       Impact factor: 9.229

7.  Aerosolizing Lipid Dispersions Enables Antibiotic Transport Across Mimics of the Lung Airway Surface Even in the Presence of Pre-existing Lipid Monolayers.

Authors:  Steven V Iasella; Amy Z Stetten; Timothy E Corcoran; Stephen Garoff; Todd M Przybycien; Robert D Tilton
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2017-10-20       Impact factor: 2.849

8.  Effect of heliox- and air-driven nebulized bronchodilator therapy on lung function in patients with asthma.

Authors:  Mohamad F El-Khatib; Ghassan Jamaleddine; Nadim Kanj; Salah Zeineddine; Hassan Chami; Imad Bou-Akl; Ahmad Husari; Marwan Alawieh; Pierre Bou-Khalil
Journal:  Lung       Date:  2014-03-19       Impact factor: 2.584

9.  Potential of a cyclone prototype spacer to improve in vitro dry powder delivery.

Authors:  Irene Parisini; Sean J Cheng; Digby D Symons; Darragh Murnane
Journal:  Pharm Res       Date:  2014-05       Impact factor: 4.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.